Form 4: Amentum Holdings Director Acquires Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Christopher M.T. Thompson, a director of Amentum Holdings, Inc., acquired 11,564 restricted stock units on April 8, 2025, according to a Form 4 filing.

Summary

  • On April 8, 2025, Christopher M.T. Thompson, a director of Amentum Holdings, Inc., acquired 11,564 restricted stock units.
  • Each restricted stock unit represents a contingent right to receive one share of AMTM common stock.
  • The restricted stock units will vest on the date of the next annual meeting of stockholders of the Issuer.
  • Following the transaction, Thompson directly owns 11,564 derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a standard transaction. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will vest on the date of the next annual meeting of stockholders.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The transaction increases the director's stake in the company, aligning their interests with those of shareholders.

Next Steps

  • The restricted stock units will vest on the date of the next annual meeting of stockholders of the Issuer.

Key Dates

DateDescription
04/08/2025Date of transaction: Christopher M.T. Thompson acquired 11,564 restricted stock units.
04/10/2025Date of signature on the Form 4 filing.

Keywords

Amentum Holdings, Director, Restricted Stock Units, AMTM, Form 4, Beneficial Ownership, Thompson

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.